Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 14, 2025; 31(2): 97239
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.97239
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.97239
Group | CXCR1 | CXCR2 | CCR2 | CCR5 |
Mild group (n = 25) | 1.02 ± 0.01 | 0.97 ± 0.01 | 1.06 ± 0.02 | 1.01 ± 0.01 |
Moderate group (n = 30) | 2.28 ± 0.07 | 2.05 ± 0.03 | 1.98 ± 0.06 | 1.49 ± 0.05 |
Severe group (n = 35) | 4.16 ± 0.16 | 4.94 ± 0.15 | 3.02 ± 0.13 | 1.98 ± 0.17 |
Variance ratio | 9.336 | 12.208 | 13.115 | 10.624 |
P value | 0.002 | 0.014 | 0.005 | 0.006 |
- Citation: Niu JW, Zhang GC, Ning W, Liu HB, Yang H, Li CF. Clinical effects of phospholipase D2 in attenuating acute pancreatitis. World J Gastroenterol 2025; 31(2): 97239
- URL: https://www.wjgnet.com/1007-9327/full/v31/i2/97239.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i2.97239